Hematología y Hemoterapia

Resultados: 409
Tipo Título / Nombre Autor(es) Año
Immunosenescence: limitations of natural killer cell-based cancer immunotherapy Tarazona R, Sánchez-Correa B, Casas-Avilés I, Campos C, Pera A, Morgado S, et al 2017
In Vitro Culture with Interleukin-15 Leads to Expression of Activating Receptors and Recovery of Natural Killer Cell Function in Acute Myeloid Leukemia Patients Sánchez-Correa B, Bergua JM, Pera A, Campos C, Arcos MJ, Bañas H, et al 2017
Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): comprehensive genetic analysis by next-generation sequencing of 480 patients Borrás N, Batlle J, Pérez-Rodríguez A, López-Fernández MF, Rodríguez-Trillo A, Lourés E, et al 2017
Application of a molecular diagnostic algorithm for haemophilia A and B using next-generation sequencing of entire F8, F9 and VWF genes Bastida Bermeja JM, González-Porras JR, Jiménez C, Benito R, Ordoñez GR, Álvarez-Román MT, et al 2017
Tratamiento de trombocitopenia inmune primaria con eltrombopag en un paciente con síndrome coronario agudo reciente Bermejo N, Sigüenza R, Ibáñez F. 2017
Diagnostic screening of paroxysmal nocturnal hemoglobinuria: Prospective multicentric evaluation of the current medical indication Morado M, Freire Sandes A, Colado E, Subirá D, Isusi P, Soledad Noya M, et al 2017
Comparison of Efficacy and Safety of Two Types of E.coli Asparaginase (Native or Pegylated) for Treatment of Adult Patients with High-Risk (HR), Philadelphia (Ph) Chromosome-Negative ALL Included in the Prospective MRD-Oriented Protocol ALL-HR-11 from the Ribera JM, Morgades M, Montesinos P, García-Cadenas I, Barba P, Soria B, et al 2016
Frequency and Prognostic Significance of the Presence of Additional Cytogenetic Abnormalitions (ACA) to the Philadelphia (Ph) Chromosome in Young Adults with ACUTE Lymphoblastic Leukemia (ALL) Treated with the ALL Ph08 Trial from the Pethema Group Motlló C, Ribera JM, Morgades M, Granada I, Montesinos P, Mercadal S, et al 2016
NCCN-IPI in Patients with Diffuse Large B CELL Lymphoma Treated with DA-R-EPOCH. Retrospective Analysis Bergua Burgues JM, López-Gómez L, Ibañez F, Suarez-Varela S, Prieto-Fernández J, Carnicero F, et al 2016
Preliminary Results of the Flugaza Trial: A Phase III Randomized, Open Label Study Comparing Azacytidine Versus Fludarabine and Cytarabine (FLUGA Scheme) in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia Montesinos P, Vives S, Martinez-Sánchez MP, Bergua J, Algarra L, Herrera P, et al 2016